Olema Pharmaceuticals (OLMA)
(Delayed Data from NSDQ)
$4.64 USD
-0.08 (-1.69%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $4.63 -0.01 (-0.22%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OLMA 4.64 -0.08(-1.69%)
Will OLMA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OLMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OLMA
Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High?
Wall Street Analysts Think Olema Pharmaceuticals (OLMA) Could Surge 433.13%: Read This Before Placing a Bet
OLMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -30.16% in 4 Weeks, Here's Why the Trend Might Reverse for Olema Pharmaceuticals (OLMA)
Novartis' Gene Therapy Meets Primary Endpoint in SMA Study
Novartis Announces Positive Results From Late-Stage Study on Fabhalta
Other News for OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OLMA Stock News
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OLMA Stock News
Olema Pharmaceuticals Holds Annual Stockholders Meeting
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OLMA Stock News
12 Health Care Stocks Moving In Monday's Intraday Session